|
1
|
Morgan E, Arnold M, Gini A, Lorenzoni V,
Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N and Bray F:
Global burden of colorectal cancer in 2020 and 2040: Incidence and
mortality estimates from GLOBOCAN. Gut. 72:338–344. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhu L, Wang R, Zhang L, Zuo C, Zhang R and
Zhao S: rs187960998 polymorphism in miR-211 prevents development of
human colon cancer by deregulation of 3'UTR in CHD5. Onco Targets
Ther. 12:405–412. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li D, Wang Q, Li N and Zhang S: miR-205
targets YAP1 and inhibits proliferation and invasion in thyroid
cancer cells. Mol Med Rep. 18:1674–1681. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Cui X, Zhang A, Liu J, Wu K, Chen Z and
Wang Q: Down-regulation of MAP2K1 by miR-539 inhibits
hepatocarcinoma progression. Biochem Biophys Res Commun.
504:784–791. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Truong AD, Rengaraj D, Hong Y, Hoang CT,
Hong YH and Lillehoj HS: Differentially expressed JAK-STAT
signaling pathway genes and target microRNAs in the spleen of
necrotic enteritis-afflicted chicken lines. Res Vet Sci.
115:235–243. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu Y, Park J, Xu E, Kim D, Lee J and Oh
YK: MicroRNA-induced reprogramming of tumor-associated macrophages
for modulation of tumor immune microenvironment. J Control Release.
381(113593)2025.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Xing Y, Ruan G, Ni H, Qin H, Chen S, Gu X,
Shang J, Zhou Y, Tao X and Zheng L: Tumor immune microenvironment
and its related miRNAs in tumor progression. Front Immunol.
12(624725)2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wen D, Li S, Jiang W, Zhu J, Liu J and
Zhao S: Retraction notice to ‘MiR-539 inhibits human colorectal
cancer progression by targeting RUNX2’ [Biomed. Pharmacother 95
(2017) 1314-1320]. Biomed Pharmacother. 167(115375)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Du Y, Rokavec M and Hermeking H: Squalene
epoxidase/SQLE is a candidate target for treatment of colorectal
cancers with p53 mutation and elevated c-MYC expression. Int J Biol
Sci. 19:4103–4122. 2023.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang Y, Wu Y, Cai A, Ma C, Cai S, Wang H,
Que Y, Xu S, Xu T and Hu Y: Cisplatin inhibits the proliferation of
Saos-2 osteosarcoma cells via the miR-376c/TGFA pathway. Bosn J
Basic Med Sci. 21:163–173. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang Z, Yang L, Yao X, Yang M and Li G:
LncRNA-ZNF281 interacts with miR-539 to promote hepatocellular
carcinoma cell invasion and migration. Cancer Biother Radiopharm.
35:137–142. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sayagués JM, Corchete LA, Gutiérrez ML,
Sarasquete ME, Del Mar Abad M, Bengoechea O, Fermiñán E, Anduaga
MF, Del Carmen S, Iglesias M, et al: Genomic characterization of
liver metastases from colorectal cancer patients. Oncotarget.
7:72908–72922. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41 (Database
Issue):D991–D995. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gustavsson EK, Zhang D, Reynolds RH,
Garcia-Ruiz S and Ryten M: ggtranscript: An R package for the
visualization and interpretation of transcript isoforms using
ggplot2. Bioinformatics. 38:3844–3846. 2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Cancer Genome Atlas Network. Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kozomara A, Birgaoanu M and
Griffiths-Jones S: miRBase: From microRNA sequences to function.
Nucleic Acids Res. 47 (D1):D155–D162. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ranjbar R, Behzadi P and Mammina C:
Respiratory tularemia: Francisella tularensis and microarray probe
designing. Open Microbiol J. 10:176–182. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Jia A, Xu L and Wang Y: Venn diagrams in
bioinformatics. Brief Bioinform. 22(bbab108)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lex A, Gehlenborg N, Strobelt H, Vuillemot
R and Pfister H: UpSet: Visualization of intersecting sets. IEEE
Trans Vis Comput Graph. 20:1983–1992. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bai H, Dai Y, Fan P, Zhou Y, Wang X, Chen
J, Jiao Y, Du C, Huang Z, Xie Y, et al: The METHYLTRANSFERASE
B-SERRATE interaction mediates the reciprocal regulation of
microRNA biogenesis and RNA m6A modification. J Integr
Plant Biol. 66:2613–2631. 2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bartel DP: Metazoan MicroRNAs. Cell.
173:20–51. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Engler DB, Leonardi I, Hartung ML, Kyburz
A, Spath S, Becher B, Rogler G and Müller A: Helicobacter
pylori-specific protection against inflammatory bowel disease
requires the NLRP3 inflammasome and IL-18. Inflamm Bowel Dis.
21:854–861. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
De Bacco F, Orzan F, Erriquez J, Casanova
E, Barault L, Albano R, D'Ambrosio A, Bigatto V, Reato G, Patanè M,
et al: ERBB3 overexpression due to miR-205 inactivation confers
sensitivity to FGF, metabolic activation, and liability to ERBB3
targeting in glioblastoma. Cell Rep. 36(109455)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Emmett SE, Stark MS, Pandeya N, Panizza B,
Whiteman DC and Antonsson A: MicroRNA expression is associated with
human papillomavirus status and prognosis in mucosal head and neck
squamous cell carcinomas. Oral Oncol. 113(105136)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li HN, Zhang HM, Li XR, Wang J, Xu T, Li
SY, Dong ML, Wang G, Cui XQ, Yang X, et al: MiR-205-5p/GGCT
attenuates growth and metastasis of papillary thyroid cancer by
regulating CD44. Endocrinology. 163(bqac022)2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kalogirou C, Linxweiler J, Schmucker P,
Snaebjornsson MT, Schmitz W, Wach S, Krebs M, Hartmann E, Puhr M,
Müller A, et al: MiR-205-driven downregulation of cholesterol
biosynthesis through SQLE-inhibition identifies therapeutic
vulnerability in aggressive prostate cancer. Nat Commun.
12(5066)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Huang W, Wu K, Wu R, Chen Z, Zhai W and
Zheng J: Bioinformatic gene analysis for possible biomarkers and
therapeutic targets of hypertension-related renal cell carcinoma.
Transl Androl Urol. 9:2675–2687. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhu H, Shan Y, Ge K, Lu J, Kong W and Jia
C: LncRNA CYTOR promotes pancreatic cancer cell proliferation and
migration by sponging miR-205-5p. Pancreatology. 20:1139–1148.
2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang H, Zhang G, Lu S, Zhang X and Yu J:
Integrated analysis of ncRNA in hepatocellular carcinoma with
CTNNB1 mutations reveals miR-205-5p and miR-3940-3p axes. Dig Liver
Dis. 57:51–61. 2025.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Donkers H, Hirschfeld M, Weiß D, Erbes T,
Jaeger M, Pijnenborg JMA, Bekkers R and Galaal K:
ENITEC-consortium. Usefulness of microRNA detection in the
diagnostics of endometrial cancer. Acta Obstet Gynecol Scand.
100:1148–1154. 2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ibuki Y, Nishiyama Y, Tsutani Y, Emi M,
Hamai Y, Okada M and Tahara H: Circulating microRNA/isomiRs as
novel biomarkers of esophageal squamous cell carcinoma. PLoS One.
15(e0231116)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li J, Li PT, Wu W, Ding BN, Wen YG, Cai
HL, Liu SX, Hong T, Zhang JF, Zhou JD, et al: POU2F2-mediated
upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast
cancer via miR-376c-3p/SLC7A11 axis. Epigenomics. 16:215–231.
2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Li Y, Zhang L, Zhao Y, Peng H, Zhang N and
Bai W: MEG3 sponges miRNA-376a and YBX1 to regulate angiogenesis in
ovarian cancer endothelial cells. Heliyon. 9(e13204)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Deng YW, Shu YG and Sun SL: miR-376a
inhibits glioma proliferation and angiogenesis by regulating
YAP1/VEGF signalling via targeting of SIRT1. Transl Oncol.
15(101270)2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu XW, Zhang CC and Zhang T: MiR-376b-3p
functions as a tumor suppressor by targeting KLF15 in non-small
cell lung cancer. Eur Rev Med Pharmacol Sci. 24:9480–9486.
2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Liu X, Chen D, Chen H, Wang W, Liu Y, Wang
Y, Duan C, Ning Z, Guo X, Otkur W, et al: YB1 regulates
miR-205/200b-ZEB1 axis by inhibiting microRNA maturation in
hepatocellular carcinoma. Cancer Commun (Lond). 41:576–595.
2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Gu L and Sun W: MiR-539 inhibits thyroid
cancer cell migration and invasion by directly targeting CARMA1.
Biochem Biophys Res Commun. 464:1128–1133. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Guo J, Gong G and Zhang B: miR-539 acts as
a tumor suppressor by targeting epidermal growth factor receptor in
breast cancer. Sci Rep. 8(2073)2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu H, Yang M, Zhang Y, Yang Z, Chen Z,
Xie Y, Peng B and Cai L: The effect of miR-539 regulating TRIAP1 on
the apoptosis, proliferation, migration and invasion of
osteosarcoma cells. Cancer Cell Int. 21(227)2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Wong MM, Aziz NA, Ch'ng ES, Armon S, Chook
JB, Bong JJ, Peh SC, Wu YS and Teow SY: Expression of LC3A, LC3B
and p62/SQSTM1 autophagy proteins in hepatocellular carcinoma (HCC)
tissues and the predicted microRNAs involved in the
autophagy-related pathway. J Mol Histol. 55:317–328.
2024.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yang Y, Lin Z, Han Z, Wu Z, Hua J, Zhong
R, Zhao R, Ran H, Qu K, Huang H, et al: miR-539 activates the
SAPK/JNK signaling pathway to promote ferropotosis in colorectal
cancer by directly targeting TIPE. Cell Death Discov.
7(272)2021.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhao J, Xu J and Zhang R: MicroRNA-539
inhibits colorectal cancer progression by directly targeting SOX4.
Oncol Lett. 16:2693–2700. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Sánchez-Tilló E, de Barrios O, Siles L,
Cuatrecasas M, Castells A and Postigo A: β-catenin/TCF4 complex
induces the epithelial-to-mesenchymal transition (EMT)-activator
ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA.
108:19204–19209. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Cortez MA, Ivan C, Valdecanas D, Wang X,
Peltier HJ, Ye Y, Araujo L, Carbone DP, Shilo K, Giri DK, et al:
PDL1 regulation by p53 via miR-34. J Natl Cancer Inst.
108(djv303)2015.PubMed/NCBI View Article : Google Scholar
|
